Search


 
Results 1 - 10 of about 63 for "From ACP Journal Club".

Review: In diabetes, intensive and standard glycemic control ...

The review suggests that treating diabetes with strict glycemic control does not reduce mortality or cardiovascular risk or slow progression of kidney disease ...

Self-monitoring of blood glucose did not improve HbA1c or ...

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according ...

In patients with type 2 diabetes and CV disease, empagliflozin ...

An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on ...

In type 1 diabetes, education with either insulin pumps or daily ...

The results showed that when patients on multiple daily insulin injections received structured education, there was no additional benefit of switching ...

Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 ...

A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the ...

Gastric bypass or biliopancreatic diversion increases ...

A randomized controlled trial (RCT) of 60 severely obese adults with type 2 diabetes found that gastric bypass or biliopancreatic diversion increased ...

An intensive lifestyle intervention increased remission from ...

In the randomized, controlled Look AHEAD trial, an intensive lifestyle intervention (ILI) was associated with partial remission of type 2 diabetes when ...

Review: Metformin is linked to reduced mortality in type 2 ...

The included studies focused on metformin use in patients with chronic kidney disease (CKD), congestive heart failure (CHF), chronic liver disease (CLD ...

In patients with type 2 diabetes and high CV risk, liraglutide ...

The study's primary composite outcome was first occurrence of death from cardiovascular (CV) causes, nonfatal (including silent) myocardial infarction ...

Review: Type 2 diabetes screening does not reduce mortality ...

A systematic evidence review by the US Preventive Services Task Force found no evidence of mortality benefit from screening for diabetes, based on ...

Result Page: 1 2 3 4 5  Next >